Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 9,198,900 | 8,490,353 | -708,547 | $294.46M | $287.74M | 38.34% | -$6.72M |
| MapLight Therapeutics, Inc.(MPLT) | 3,226,400 | 3,226,400 | 0 | $65.59M | $115.63M | 15.41% | +$50.04M |
| Dyne Therapeutics, Inc.(DYN) | 4,644,386 | 3,848,256 | -796,130 | $84.20M | $85.47M | 11.39% | +$1.27M |
| Vor Biopharma Inc.(VOR) | 4,117,354 | 4,117,354 | 0 | $73.45M | $75.80M | 10.10% | +$2.35M |
| Damora Therapeutics, Inc.(DMRA) | 2,441,000 | 2,441,000 | 0 | $63.22M | $63.49M | 8.46% | +$268.5K |
| Replimune Group, Inc.(REPL) | 2,808,368 | 2,808,368 | 0 | $21.48M | $31.09M | 4.14% | +$9.60M |
| Crescent Biopharma, Inc.(CBIO) | 1,677,852 | 1,677,852 | 0 | $30.82M | $30.20M | 4.02% | -$620.8K |
| Aura Biosciences, Inc.(AURA) | 0 | 4,053,775 | +4,053,775 | $0 | $28.78M | 3.84% | +$28.78M |
| Engene Holdings Inc COM | 9,632,561 | 9,632,561 | 0 | $65.60M | $16.66M | 2.22% | -$48.93M |
| Bicycle Therapeutics PlcADS | 3,468,430 | 3,468,430 | 0 | $16.09M | $14.71M | 1.96% | -$1.39M |
| Engene Holdings IncW EXP 10 31 2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $7.28M | $834.4K | 0.11% | -$6.45M |